glp and glp 1 Glucagon-like peptide in health disease GLP-1-based therapies for type 2

Targeting SOD1 reduces experimental non-small-cell lung cancer

2009 Aug;47(8):2124-8

FIGURE 3 Overall, most studies indicate that virtually all cells involved in skin repair (fibroblasts, keratinocytes, inflammatory cells, tissue stem cells, and vascular endothelial cells) express both ER and ER and are direct targets of E2 (Matsubara and Matsubara, 2012

Approved in 2017 as Ozempic for type 2 diabetes, it offered once-weekly dosing with powerful results: significantly lowering blood sugar, reducing A1C by over 1%, and cutting the risk of major cardiovascular events like heart attack and stroke in high-risk patients